Data shown is for informational purposes only and does not constitute investment advice. TopFund is not SEBI-registered. Consult a SEBI-registered advisor before investing.
Anondita Medicare IPO
Price Band
₹137.0–145.0
Issue Size
₹69.5 Cr
Lot Size
1,000 shares
Min Investment
₹290,000
2 LOTS MIN
GMP
+₹89.0 (61.38%)
Issue Price
₹145.0
Subject to Sauda
₹67600
Paid only if allotted
Anondita Medicare IPO AI Summary
- Anondita Medicare IPO is listed on NSE SME in the Personal Care sector.
- Price band: ₹137.0–₹145.0 per share, lot size 1,000 shares (min. investment ₹290,000, 2 lots minimum).
- Subscription window: 22 Aug–26 Aug 2025, listing on 01 Sep 2025.
- Current GMP is +₹89.0 (61.38%), an estimated listing price of ₹234 — unofficial and can change daily.
Anondita Medicare Limited is an emerging player in the personal care sector, focusing on flavored male condoms. With a strong manufacturing base and export capabilities, the company aims to leverage its growth potential through this IPO.
TopFund is not SEBI-registered — this is educational analysis, not personalized investment advice.
Anondita Medicare IPO — Third-Party Research Views
Reviews below reflect analyst calls made before this IPO closed on 26 Aug 2025 — not a current signal.
Recommendations are sourced from third-party research firms and are not TopFund's own investment advice.
Important Dates
Subscription Status
Subscription data unavailable
Anondita Medicare IPO Grey Market Premium (GMP) Today
GMP
+₹89.0
GMP %
+61.38%
Est. Listing
₹234.0
Updated: 25 Jul 2026 14:13
About the Company
Founded in March 2024, Anondita Medicare Limited manufactures flavored male condoms, with its flagship product branded as “COBRA.” The company produces 562 million condoms annually. The company has a manufacturing facility situated in Noida, Uttar Pradesh. Anondita Medicare exports its products to several international markets, including Southeast Asia, Africa, and the Middle East. The company collaborates with global health organizations, NGOs, and governments to support family planning and public health initiatives. Anondita Medicare has a robust distribution network that ensures the timely delivery of its products to various markets. The company collaborates with wholesalers, retailers, and e-commerce platforms to make its products widely accessible. It also has strong ties with government health programs and institutions, playing a key role in supplying essential medical products for public health initiatives. As on July 31, 2025, the Company had 280 employees. Competitive Strength: Experienced and significant condom manufacturer in India. Well-recognized in North India Offers a diverse range of products.
Company Financials (₹ Cr)
As of 2025-03-31
| Period Ended | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|
| Assets | 78.27 | 42.92 | 37.80 |
| Total Income | 77.13 | 46.56 | 36.14 |
| Profit After Tax | 16.42 | 3.84 | 0.35 |
| EBITDA | 25.65 | 9.09 | 3.58 |
| NET Worth | 37.87 | 10.59 | 8.69 |
| Reserves and Surplus | 24.58 | 10.39 | 6.55 |
| Total Borrowing | 27.39 | 24.01 | 22.66 |
Key Ratios
EPS
₹12.35
NAV
₹28.49
ROE
41.71%
ROCE
37.42%
RoNW
41.71%
P/B Value
15.07
P/E Ratio
11.74
Market Cap
₹262.26 Cr
PAT Margin
21.32%
Debt/Equity
0.70
Peer Comparison
| Company | NAV | RoNW | P/E (x) | EPS Basic | EPS Diluted |
|---|---|---|---|---|---|
| Cupid Ltd. | 12.75 | 11.96% | 110.38 | 1.52 | 1.52 |
| Anondita Medicare Limited This IPO | 21.32 | 38.1% | — | 9.6 | 9.6 |
Promoters
Anupam Ghosh, Sonia Ghosh and Reshant Ghosh
Objects of the Issue
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects: # Issue Objects Est Amt (₹ Cr.) 1 Funding capital expenditure requirements for the purchase of equipment/machineries 6.00 2 Funding the working capital requirements of the Company 35.00 3 Unidentified Acquisition and General Corporate Purposes 20.16 4 Issue Expenses 8.34 Total 69.50
IPO Evaluation
Generated 23 Sep 2026Revenue Trend
Total income was ₹36.14 Cr in the period ending 31 Mar 2023, rising to ₹46.56 Cr by 31 Mar 2024, and further increasing to ₹77.13 Cr by 31 Mar 2025.
Profit Trend
Profit After Tax was ₹0.35 Cr in the period ending 31 Mar 2023, increasing to ₹3.84 Cr by 31 Mar 2024, and further growing to ₹16.42 Cr by 31 Mar 2025.
Valuation
Anondita Medicare's implied P/E at the issue price is approximately 11.74, compared to peers like Cupid Ltd. which has a P/E of 110.38.
Grey Market Premium, Explained
The Grey Market Premium (GMP) indicates the expected listing price of an IPO based on unofficial trading before it officially lists on the stock exchange. A positive GMP suggests strong demand for the IPO, while a negative GMP may indicate weak interest.
Who This IPO Suits
Investors comfortable with short-term volatility and a long-term horizon typically weigh IPOs like this against their overall investment strategy and risk tolerance. It's important to consider the company's growth potential and market conditions.
Who May Want to Wait
Investors who are risk-averse or prefer stable, established companies may want to avoid IPOs like this, which can be subject to significant price fluctuations in the early trading days.
IPO Timeline, Explained
The IPO opens for subscription on 22 Aug 2025 and closes on 26 Aug 2025, with allotment scheduled for 28 Aug 2025 and listing on 01 Sep 2025.
Listing Gains — The Risk
Listing-day gains can be unpredictable. While some IPOs may experience a surge in price upon listing, others may not perform as well, and investors should be prepared for the possibility of volatility.
This evaluation is generated from Anondita Medicare's own public IPO filing data for educational purposes and is not investment advice or a recommendation to apply, subscribe to, or avoid this issue — see Broker Recommendations below for named third-party research views (clearly attributed, not TopFund's own). TopFund is not a SEBI-registered investment adviser — see our Disclaimer.
Frequently Asked Questions
What is Anondita Medicare IPO GMP today?
Anondita Medicare IPO GMP today is +₹89.0 (61.38%), indicating an estimated listing price of ₹234. GMP is an unofficial grey-market indicator and can change daily.
What is the price band of Anondita Medicare IPO?
The price band of Anondita Medicare IPO is ₹137.0–₹145.0 per share.
When does Anondita Medicare IPO open and close?
Anondita Medicare IPO opens on 22 August 2025 and closes on 26 August 2025.
When does Anondita Medicare IPO list on the stock exchange?
Anondita Medicare IPO listed on 01 September 2025 at ₹234.0.
What is the lot size for Anondita Medicare IPO?
The lot size for Anondita Medicare IPO is 1000 shares, requiring a minimum investment of ₹290,000 (2 lots).
What is the price band for the Anondita Medicare IPO?
The price band for the Anondita Medicare IPO is ₹137.0 to ₹145.0.
What is the minimum investment required?
The minimum investment required is ₹290,000.
What is the lot size for the IPO?
The lot size for the IPO is 1000 shares.
When does the IPO open and close?
The IPO opens on 22 Aug 2025 and closes on 26 Aug 2025.
What does GMP mean?
GMP stands for Grey Market Premium, which indicates the expected listing price of the IPO based on unofficial trading.
Issue Details
Investor Allocation
Registrar
Lead Managers / Book Running
IPO Timeline
Open
22 Aug 2025
Close
26 Aug 2025
Allotment
28 Aug 2025
Listing
01 Sep 2025
Similar IPOs in Personal Care
Plan Your IPO Investment
Related Articles
Community Sentiment
What are other investors planning for Anondita Medicare?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
No comments yet — start the discussion.